This feature is a deep dive into the challenges of defining and treating Difficult-to-Treat Rheumatoid Arthritis (D2T-RA).

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Senior doctors at the Sharon Hospital report that terrorists receive and compassing medical care an Israeli hospitals, sometimes beyond what is necessary.